相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)
Robert L. Ferris et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
Sue S. Yom et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01)-A Trans-Tasman Radiation Oncology Group Study
Danny Rischin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status
Zoe H. Fullerton et al.
CANCER (2020)
Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma
Josefine Freitag et al.
CANCER (2020)
Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer
Krystle A. Lang Kuhs et al.
CANCER (2020)
Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification
Shao Hui Huang et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome
Sarah Deschuymer et al.
RADIOTHERAPY AND ONCOLOGY (2020)
De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies
Hisham Mehanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil
Rodrigo Lopes da Silva et al.
BMC WOMENS HEALTH (2020)
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region
Jianjun Ren et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals
Joseph E. Tota et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Prevalence of Oral HPV Infection in Unvaccinated Men and Women in the United States, 2009-2016
Anil K. Chaturvedi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma
Daniel J. Ma et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus?Associated Oropharyngeal Squamous Cell Carcinoma
Bhishamjit S. Chera et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial
Anthony C. Nichols et al.
LANCET ONCOLOGY (2019)
Human papillomavirus and the landscape of secondary genetic alterations in oral cancers
Maura L. Gillison et al.
GENOME RESEARCH (2019)
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Hisham Mehanna et al.
LANCET (2019)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison et al.
LANCET (2019)
Human Papillomavirus Testing in Head and Neck Carcinomas Guideline From the College of American Pathologists
James S. Lewis et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Mature Results of a Prospective Study of Deintensified Chemoradiotherapy for Low-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
Bhishamjit S. Chera et al.
CANCER (2018)
Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States
Anil K. Chaturvedi et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project
Pernille Lassen et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications
Diana J. Lu et al.
EUROPEAN JOURNAL OF CANCER (2018)
Differences in the viral genome between HPV- positive cervical and oropharyngeal cancer
Bailey A. LeConte et al.
PLOS ONE (2018)
Patient-Reported Quality-of-Life Outcomes After De-Escalated Chemoradiation for Human Papillomavirus-Positive Oropharyngeal Carcinoma: Findings From a Phase 2 Trial
John V. Hegde et al.
CANCER (2018)
Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis
Elena-Sophie Prigge et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer
Carole Fakhry et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx-ECOG-ACRIN Cancer Research Group
Shanthi Marur et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
Allen M. Chen et al.
LANCET ONCOLOGY (2017)
The Prognostic Value of Extranodal Extension in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
Yi An et al.
CANCER (2017)
Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline
David J. Sher et al.
PRACTICAL RADIATION ONCOLOGY (2017)
Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status
Annekatrin Coordes et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2016)
Matted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer
Jeffrey M. Vainshtein et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery
John M. Kaczmar et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Increase in Primary Surgical Treatment of T1 and T2 Oropharyngeal Squamous Cell Carcinoma and Rates of Adverse Pathologic Features: National Cancer Data Base
Jennifer R. Cracchiolo et al.
CANCER (2016)
Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories
Kristina R. Dahlstrom et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Human Papillomavirus and Oropharyngeal Cancer Stage
Maura L. Gillison
JOURNAL OF CLINICAL ONCOLOGY (2016)
Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer
Ilir Agalliu et al.
JAMA ONCOLOGY (2016)
Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer
N. Gopalakrishna Iyer et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer
Parul Sinha et al.
ORAL ONCOLOGY (2015)
The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck
A. Psyrri et al.
ANNALS OF ONCOLOGY (2014)
New treatment strategies for HPV-positive head and neck cancer
B. Kofler et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2014)
Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma
Carole Fakhry et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
Cathy Ndiaye et al.
LANCET ONCOLOGY (2014)
Human Papillomavirus Prevalence in Oropharyngeal Cancer before Vaccine Introduction, United States
Martin Steinau et al.
EMERGING INFECTIOUS DISEASES (2014)
Extracapsular spread in head and neck carcinoma: Impact of site and human papillomavirus status
Jessica H. Maxwell et al.
CANCER (2013)
Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancersystematic review and meta-analysis of trends by time and region
Hisham Mehanna et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
Controversies in Treatment Deintensification of Human Papillomavirus-Associated Oropharyngeal Carcinomas: Should We, How Should We, and for Whom?
Harry Quon et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Deintensification Candidate Subgroups in Human Papillomavirus-Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
Brian O'Sullivan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Margin Mapping in Transoral Surgery for Head and Neck Cancer
Michael L. Hinni et al.
LARYNGOSCOPE (2013)
Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century
Adam S. Garden et al.
RADIATION ONCOLOGY (2013)
Toxicity and Outcome of Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy for Oropharyngeal Cancer: A Matched-Pair Analysis
Abrahim Al-Mamgani et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2013)
Validation of Methods for Oropharyngeal Cancer HPV Status Determination in US Cooperative Group Trials
Richard C. Jordan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma
Parul Sinha et al.
CANCER (2012)
Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia
David J. Adelstein et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Matted nodes: Poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status
Matthew E. Spector et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Prevalence of Oral HPV Infection in the United States, 2009-2010
Maura L. Gillison et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer
Maura L. Gillison et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer
Bruce H. Haughey et al.
LARYNGOSCOPE (2012)
Transoral Endoscopic Surgery New Surgical Techniques for Oropharyngeal Cancer
Ryan J. Li et al.
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA (2012)
Management of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Cancer
Ranee Mehra et al.
SEMINARS IN RADIATION ONCOLOGY (2012)
Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory Papillomatosis
Maura L. Gillison et al.
VACCINE (2012)
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
M. R. Posner et al.
ANNALS OF ONCOLOGY (2011)
TRANSORAL LASER MICROSURGERY AS PRIMARY TREATMENT FOR ADVANCED-STAGE OROPHARYNGEAL CANCER: A UNITED STATES MULTICENTER STUDY
Bruce H. Haughey et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Anil K. Chaturvedi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice
Selvam Thavaraj et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Human Papillomavirus Detection in Head and Neck Squamous Cell Carcinomas
Anthony N. Snow et al.
ADVANCES IN ANATOMIC PATHOLOGY (2010)
MULTI-INSTITUTIONAL TRIAL OF ACCELERATED HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY FOR EARLY-STAGE OROPHARYNGEAL CANCER (RTOG 00-22)
Avraham Eisbruch et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
Danny Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer
Gypsyamber D'Souza et al.
ORAL ONCOLOGY (2010)
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?
Anders Nasman et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck
Pernille Lassen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States
Anil K. Chaturvedi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
Carole Fakhry et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck
Shahnaz Begum et al.
CLINICAL CANCER RESEARCH (2007)
Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis
PM Weinberger et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Defining risk levels in locally advanced head and neck cancers:: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501)
J Bernier et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2005)
Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma
F Denis et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
J Bernier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
JS Cooper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
ML Gillison et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
